Literature DB >> 19540760

Muscle ultrasound measurements and functional muscle parameters in non-dystrophic myotonias suggest structural muscle changes.

J Trip1, S Pillen, C G Faber, B G M van Engelen, M J Zwarts, G Drost.   

Abstract

Patients with non-dystrophic myotonias, including chloride (myotonia congenita) and sodium channelopathies (paramyotonia congenita/potassium aggravated myotonias), may show muscular hypertrophy in combination with some histopathological abnormalities. However, the extent of muscle changes has never been assessed objectively in a large group genetically confirmed patients. This study quantitatively determines echo intensities, thicknesses, ranges-of-motion and force of four skeletal muscles in 63 genetically confirmed patients. The main findings revealed elevated echo intensities in all muscles except the rectus femoris (+1.3-2.2SD, p<0.0001), and hypertrophy in the arms (+0.5-0.9SD, p<0.01). Muscle echo intensities were inversely correlated to the corresponding ranges-of-motion (biceps brachii: r= -0.43; p<0.001, forearm flexors: r= -0.47; p<0.001, rectus femoris: r= -0.40; p=0.001, and tibial anterior: r= -0.27; p=0.04) and correlated positively to age (r=0.22; p=0.05). The echo intensity of the forearm flexors was inversely correlated to their muscles' force (r= -0.30; p=0.02). Together, these data suggest that non-dystrophic myotonias may lead to structural muscle changes.

Entities:  

Mesh:

Year:  2009        PMID: 19540760     DOI: 10.1016/j.nmd.2009.06.369

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  15 in total

1.  Lean and fat mass loss in obese patients before and after Roux-en-Y gastric bypass: a new application for ultrasound technique.

Authors:  A Z Pereira; J S Marchini; G Carneiro; C H Arasaki; M T Zanella
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

Review 2.  Muscle quality in aging: a multi-dimensional approach to muscle functioning with applications for treatment.

Authors:  Maren S Fragala; Anne M Kenny; George A Kuchel
Journal:  Sports Med       Date:  2015-05       Impact factor: 11.136

3.  Quantitative ultrasound of muscle can detect corticosteroid effects.

Authors:  Maria G Martucci; Courtney E McIlduff; Carmen Shin; Hilda V Gutierrez; Joo Yeon Nam; Patricia Greenstein; Kester Phillips; Erik J Uhlmann; Eric T Wong; Seward B Rutkove
Journal:  Clin Neurophysiol       Date:  2019-05-10       Impact factor: 3.708

Review 4.  Guidelines on clinical presentation and management of nondystrophic myotonias.

Authors:  Bas C Stunnenberg; Samantha LoRusso; W David Arnold; Richard J Barohn; Stephen C Cannon; Bertrand Fontaine; Robert C Griggs; Michael G Hanna; Emma Matthews; Giovanni Meola; Valeria A Sansone; Jaya R Trivedi; Baziel G M van Engelen; Savine Vicart; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2020-05-27       Impact factor: 3.217

Review 5.  The paradox of muscle hypertrophy in muscular dystrophy.

Authors:  Joe N Kornegay; Martin K Childers; Daniel J Bogan; Janet R Bogan; Peter Nghiem; Jiahui Wang; Zheng Fan; James F Howard; Scott J Schatzberg; Jennifer L Dow; Robert W Grange; Martin A Styner; Eric P Hoffman; Kathryn R Wagner
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-02       Impact factor: 1.784

6.  Skeletal muscle quality assessed from echo intensity is associated with muscle strength of middle-aged and elderly persons.

Authors:  Yoshihiro Fukumoto; Tome Ikezoe; Yosuke Yamada; Rui Tsukagoshi; Masatoshi Nakamura; Natsuko Mori; Misaka Kimura; Noriaki Ichihashi
Journal:  Eur J Appl Physiol       Date:  2011-08-17       Impact factor: 3.078

7.  Quantitative ultrasound of skeletal muscle: reliable measurements of calibrated muscle backscatter from different ultrasound systems.

Authors:  Craig M Zaidman; Mark R Holland; Michael S Hughes
Journal:  Ultrasound Med Biol       Date:  2012-07-03       Impact factor: 2.998

Review 8.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Authors:  E Matthews; D Fialho; S V Tan; S L Venance; S C Cannon; D Sternberg; B Fontaine; A A Amato; R J Barohn; R C Griggs; M G Hanna
Journal:  Brain       Date:  2009-11-16       Impact factor: 13.501

9.  Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.

Authors:  Bas C Stunnenberg; Willem Woertman; Joost Raaphorst; Jeffrey M Statland; Robert C Griggs; Janneke Timmermans; Christiaan G Saris; Bas J Schouwenberg; Hans M Groenewoud; Dick F Stegeman; Baziel G M van Engelen; Gea Drost; Gert Jan van der Wilt
Journal:  BMC Neurol       Date:  2015-03-25       Impact factor: 2.474

10.  Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias.

Authors:  Jasper M Morrow; Emma Matthews; Dipa L Raja Rayan; Arne Fischmann; Christopher D J Sinclair; Mary M Reilly; John S Thornton; Michael G Hanna; Tarek A Yousry
Journal:  Neuromuscul Disord       Date:  2013-06-27       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.